Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer statistics, 2022
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 1, pp. 7-33
Open Access | Times Cited: 14310

Showing 1-25 of 14310 citing articles:

Cancer statistics, 2023
Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle, et al.
CA A Cancer Journal for Clinicians (2023) Vol. 73, Iss. 1, pp. 17-48
Open Access | Times Cited: 11514
Cancer treatment and survivorship statistics, 2022
Kimberly D. Miller, Letícia Nogueira, Theresa P. Devasia, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 5, pp. 409-436
Open Access | Times Cited: 2886
Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia, Xuesi Dong, Li He, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 5, pp. 584-590
Open Access | Times Cited: 2555
Breast Cancer Statistics, 2022
Angela N. Giaquinto, Hyuna Sung, Kimberly D. Miller, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 6, pp. 524-541
Open Access | Times Cited: 1631
Hepatocellular carcinoma
Arndt Vogel, Tim Meyer, Gonzalo Sapisochín, et al.
The Lancet (2022) Vol. 400, Iss. 10360, pp. 1345-1362
Closed Access | Times Cited: 1290
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
David S. Ettinger, Douglas E. Wood, Dara L. Aisner, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 5, pp. 497-530
Closed Access | Times Cited: 1047
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Margaret von Mehren, John M. Kane, Mark Agulnik, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 7, pp. 815-833
Open Access | Times Cited: 964
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015–2019
Quinn T. Ostrom, Mackenzie Price, Corey Neff, et al.
Neuro-Oncology (2022) Vol. 24, Iss. Supplement_5, pp. v1-v95
Open Access | Times Cited: 932
Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Meena S. Moran, Jame Abraham, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 6, pp. 691-722
Open Access | Times Cited: 740
The global burden of lung cancer: current status and future trends
Amanda Leiter, Rajwanth Veluswamy, Juan P. Wisnivesky
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 9, pp. 624-639
Closed Access | Times Cited: 526
Lung cancer immunotherapy: progress, pitfalls, and promises
Aritraa Lahiri, Avik Maji, Pravin D. Potdar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 499
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 486
American Cancer Society nutrition and physical activity guideline for cancer survivors
Cheryl L. Rock, Cynthia A. Thomson, Kristen Sullivan, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 3, pp. 230-262
Open Access | Times Cited: 467
Cancer statistics for African American/Black People 2022
Angela N. Giaquinto, Kimberly D. Miller, Katherine Y. Tossas, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 3, pp. 202-229
Open Access | Times Cited: 449
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer
Mansoor Raza Mirza, Dana M. Chase, Brian M. Slomovitz, et al.
New England Journal of Medicine (2023) Vol. 388, Iss. 23, pp. 2145-2158
Open Access | Times Cited: 447
Epidemiology of Renal Cell Carcinoma: 2022 Update
Laura Bukavina, Karim Bensalah, Freddie Bray, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 529-542
Closed Access | Times Cited: 388
Clinical management of metastatic colorectal cancer in the era of precision medicine
Fortunato Ciardiello, Davide Ciardiello, Giulia Martini, et al.
CA A Cancer Journal for Clinicians (2022) Vol. 72, Iss. 4, pp. 372-401
Open Access | Times Cited: 354
Non‐small cell lung cancer in China
Peixin Chen, Yunhuan Liu, Yaokai Wen, et al.
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 937-970
Open Access | Times Cited: 345
Annual report to the nation on the status of cancer, part 1: National cancer statistics
Kathleen A. Cronin, Susan Scott, Albert U. Firth, et al.
Cancer (2022) Vol. 128, Iss. 24, pp. 4251-4284
Open Access | Times Cited: 342
Metastasis
Stefanie Gerstberger, Qingwen Jiang, Karuna Ganesh
Cell (2023) Vol. 186, Iss. 8, pp. 1564-1579
Open Access | Times Cited: 339
Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology
Nadeem R. Abu‐Rustum, Catheryn M. Yashar, Rebecca C. Arend, et al.
Journal of the National Comprehensive Cancer Network (2023) Vol. 21, Iss. 2, pp. 181-209
Closed Access | Times Cited: 337
2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
Oskar Bergengren, Kelly Pekala, Konstantina Matsoukas, et al.
European Urology (2023) Vol. 84, Iss. 2, pp. 191-206
Open Access | Times Cited: 327
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin, et al.
Journal of Clinical Oncology (2023) Vol. 42, Iss. 1, pp. 47-58
Open Access | Times Cited: 325
Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Robert I. Haddad, Lindsay A. Bischoff, Douglas W. Ball, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 8, pp. 925-951
Open Access | Times Cited: 320
Survival with Cemiplimab in Recurrent Cervical Cancer
Krishnansu S. Tewari, Bradley J. Monk, Ignace Vergote, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 6, pp. 544-555
Open Access | Times Cited: 303
Page 1 - Next Page

Scroll to top